Table 2

Characteristics of fatalities

IRDPsARARARAPsARA
Age (years)647080805972
GenderMMFFMF
BMI (kg/m2)40.627.828.723.927.826.6
Antirheumatic therapyGCSSZGC, MTXGC, MTX, RTXGC, SSZGC, MTX, ABC
ComorbiditiesCVD
COPD
AHTCVD
AHT
COPD
AHT
Osteoporosis
CVD
AHT
Cancer
Other
AHT
COPD
Disease duration
(COVID-19)
6 days8 days14 days21 days18 days20 days
Symptoms
(COVID-19)
Fever
Dyspnea
Fever
Cough
Fever
Dyspnea
Chest pain
Fever
Cough
Dyspnea
Vertigo
Fatigue
Fever
Dyspnea
Cough
Dyspnea
Invasive ventilationYesYesYesYesYesYes
Interruption DMARDYesYesYes, MTXYes, MTX and RTXNoYes, ABC and MTX
  • ABC, abatacept; AHT, arterial hypertension; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular diseases; DMARD, disease-modifying antirheumatic drugs; F, female; GC, glucocorticosteroids; IRD, inflammatory rheumatic diseases; M, male; MTX, methotrexate; PsA, psoriatic arthritis; RA, rheumatoid arthritis; RTX, rituximab; SSZ, sulphasalazine.